Acknowledgements
The author would like to pay tribute to the late Dr Philip Thorpe for his pioneered research on phosphatidylserine and development of a series of PS-targeting antibodies. The authors thank Peregrine Pharmaceuticals Inc, Tustin, California, for the provision of PGN635 antibody.
Declaration of Conflicting Interests The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: GBM research has been supported in part by NIH R01 CA194578 (DZ), Wells Fargo Scholar Program (DZ), and the Wake Forest Baptist Comprehensive Cancer Center’s NCI Cancer Center (grant P30CA012197), as well as a grant from the Department of Veteran’s Affairs I01BX002559 (AH).
Market Data 
Markets 
AI
